download
print
% Change:
Volume:
52-Week High:
52-Week Low:

EVENTS & PRESENTATIONS

Alnylam 2025 R&D Day

Learn More ›

Alnylam Pharmaceuticals Q4 2024 Earnings Conference Call

Past Events ›

43rd Annual J.P. Morgan Healthcare Conference

Past Events ›

View all events and presentations ›
container-970 d-flex flex-1

2023 Annual Report

Download

2023 Corporate Responsibility Report

Download

capella

Investor & Scientific Presentations

Explore Capella ›

Investor Toolkit

Quarterly Earnings Presentation - Icon

Q4 2024 Earnings Presentation VIEW PDF ›

10-K - Icon

Latest Form 10-K VIEW PDF ›

10-Q - Icon

Latest Form10-Q VIEW PDF ›

sec-icon

SEC
Filings VIEW All ›

sec-icon

2024 Proxy
Statement LEARN MORE ›

View all resources and documents ›

Discover Our Commitment to Patients, Employees, and Our Communities

Corporate Responsibility ›

PRESS RELEASES

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress

Learn More ›

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results

Learn More ›

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals

Learn More ›

View all press releases ›